期刊文献+

雷公藤多甙治疗48例糖尿病肾病患者的长期疗效观察 被引量:5

Long-term efficacy of GTW on 48 cases of diabetic nephropathy
下载PDF
导出
摘要 目的:观察雷公藤多甙片对糖尿病肾病的长期临床治疗效果。方法:选取北京协和医院中医科2015年1月-2017年1月门诊的糖尿病肾病患者48例。所有患者予控制血糖、血压、血脂等西医基础治疗。采用自身前后对照研究,在治疗前、治疗3个月、治疗6个月、治疗12个月的时候,观察患者24h尿蛋白定量指标变化,并观察血清白蛋白、血肌酐的变化,同时监测血常规及肝功能。结果:经治疗3个月、6个月、12个月均提示24h尿蛋白定量较前下降,治疗12个月终点血清白蛋白上升,治疗前后差异具有统计学意义(P <0.05),血肌酐治疗前后差异无统计学意义(P> 0.05)。结论:雷公藤多甙长期用于治疗糖尿病肾病患者可以减少蛋白尿,提升血清白蛋白,保护肾功能,且安全性可靠。 Objective To observe the long-term clinical efect of GTW on diabetic nephropathy. Methods: 48 patients were given control blood sugar, blood pressure, blood lipids. The changes of 24-hour urinary protein quantification, serum albumin and serum creatinine were observed by self-contrast studies before treatment, at 3 months, 6 months and 12 months. Blood routine and liver function were monitored. Results: After 3 months, 6 months and 12 months, the 24-hour urinary protein quantification was lower than before treatment, and the serum albumin increased after 12 months, with statistically signifcant diferences (P〈0.05). The diference of serum creatinine before and after treatment did not show statistically signifcant (P〉0.05). Conclusion: GTW can reduce proteinuria, increase serum albumin, protect renal function, and provide reliable safety.
出处 《中医临床研究》 2018年第26期62-63,共2页 Clinical Journal Of Chinese Medicine
关键词 糖尿病肾病 蛋白尿 雷公藤多甙片 Diabetic nephropathy Urine protein GTW
  • 相关文献

参考文献3

二级参考文献13

  • 1杜勇,杨念生,李幼姬,姜宗培,姜傥,余学清.2型糖尿病患者合并非糖尿病肾损害的临床病理分析[J].中华糖尿病杂志(1006-6187),2004,12(6):409-412. 被引量:20
  • 2Ceriello A.New insights on oxidative stress and diabetic complications may lead to"causal"antioxidant therapy[J].Diabetes Care,2003,26(5):1589-1596.
  • 3Body-White J,Williams JC.Effect of cross-linking on matrixperme ability:a model for AGE2 modified basementmembranes[J].Kidney Int,1996,46(3):348-353.
  • 4Karamanos B,Porta M,Songini M,et al.Different risk factors of microangiopathy in patients with type 1 diabetes mellitus of shorter long duration:the Eurodiab IDDM Comp lications Study[J].Diabetologia,2000,43(3):348-355.
  • 5Barroso LC,Herrera ND,Hueros JC.et al.lncidence of cardiovascular disease and vajidity of equations of coronary risk in diabeticpatients with metabolic syndrome[J].Med Clin(Barc),2007,128(14):529-535.
  • 6No authors listed.Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes:UKFDS 391UK Prospective Diabetes Study Group[J],BMJ,1998,317(7160):713-720.
  • 7Dai C,Stolz DB,Bastacky SI,et al.Essential role of integrinlinkedkinase in podocyte biology:bridging the Integrin and slit diaphragm signaling[J].J Am Soc Nephrol,2006.17(8):2164-2175.
  • 8Kim SI,Kwak JH.Zachariah M.et al.TGF2-activated kinase 1 andTAK 1-binding protein 1 cooperate to mediate TGF212 inducedMKK32p38 MAPK activation and stimulation of type Ⅰ collagen[J].AmJ Physiol Renal Physiol,2007,292(5):1471-1478.
  • 9Huang CC,J inn YG,Shyi JS,et al.Insulin and heparin suppress peroxide production in diabetic ratglomeruli stimulated with low-density Lipoprotein[J].Kidney Int,2001,59(1):124-130.
  • 10Park YS,Gudarro C,Kim Y,et al.Lovastin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein21 mRNA in nephritic rats[J].Am J Kidney Dis,1998,31(1):190-197.

共引文献141

同被引文献87

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部